HCPCS Level II · Drugs administered other than oral method
J0873Injection, daptomycin (xellia), not therapeutically equivalent to j0878 or j0872, 1 mg
✓ Active
Source: CMS HCPCS quarterly update, October 2026. Page updated September 29, 2026.
About J0873
J0873 is an HCPCS Level II code in the J series (drugs administered other than oral method), describing injection, daptomycin (xellia), not therapeutically equivalent to j0878 or j0872, 1 mg.
It was added to HCPCS effective 01/01/2024, and its current record took effect 01/01/2025.
Its Medicare coverage code is "C", meaning coverage is left to the Medicare contractor's judgment.
Details
- Short description
- Inj daptomycin (xellia)
- Date added
- 01/01/2024
- Action effective
- 01/01/2025
- BETOS
- O1E
Related J08xx codes
- J0801Injection, corticotropin (acthar gel), up to 40 units
- J0802Injection, corticotropin (ani), up to 40 units
- J0834Injection, cosyntropin, 0.25 mg
- J0840Injection, crotalidae polyvalent immune fab (ovine), up to 1 gram
- J0841Injection, crotalidae immune f(ab')2 (equine), 120 mg
- J0850Injection, cytomegalovirus immune globulin intravenous (human), per vial
- J0870Injection, imetelstat, 1 mg
- J0871Injection, daptomycin (endo), not therapeutically equivalent to j0878, 1 mg
- J0872Injection, daptomycin (xellia), unrefrigerated, not therapeutically equivalent to j0878 or j0873, 1 mg
- J0874Injection, daptomycin (baxter), not therapeutically equivalent to j0878, 1 mg
- J0875Injection, dalbavancin, 5 mg
- J0877Injection, daptomycin (hospira), not therapeutically equivalent to j0878, 1 mg
Common questions about J0873
Is HCPCS J0873 still valid?
- Yes. J0873 is active in the CMS October 2026 HCPCS file.
Does Medicare cover J0873?
- Its coverage code is "C": coverage is left to the Medicare contractor's judgment. Check the local coverage determination for your region.